U.S. flag

An official website of the United States government

NM_001374736.1(DST):c.20438A>G (p.Asn6813Ser) AND Hereditary sensory and autonomic neuropathy type 6

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 2, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:

Allele description [Variation Report for NM_001374736.1(DST):c.20438A>G (p.Asn6813Ser)]

NM_001374736.1(DST):c.20438A>G (p.Asn6813Ser)

DST:dystonin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_001374736.1(DST):c.20438A>G (p.Asn6813Ser)
  • NC_000006.12:g.56493046T>C
  • NG_029322.2:g.466583A>G
  • NM_001144769.5:c.14081A>G
  • NM_001144770.2:c.13667A>G
  • NM_001374722.1:c.20438A>G
  • NM_001374729.1:c.19478A>G
  • NM_001374730.1:c.13220A>G
  • NM_001374734.1:c.20465A>G
  • NM_001374736.1:c.20438A>GMANE SELECT
  • NM_001386100.1:c.13547A>G
  • NM_015548.5:c.12569A>G
  • NM_183380.4:c.13547A>G
  • NP_001138241.1:p.Asn4694Ser
  • NP_001138242.1:p.Asn4556Ser
  • NP_001361651.1:p.Asn6813Ser
  • NP_001361658.1:p.Asn6493Ser
  • NP_001361659.1:p.Asn4407Ser
  • NP_001361663.1:p.Asn6822Ser
  • NP_001361665.1:p.Asn6813Ser
  • NP_001373029.1:p.Asn4516Ser
  • NP_056363.2:p.Asn4190Ser
  • NP_899236.1:p.Asn4516Ser
  • NC_000006.11:g.56357844T>C
  • NM_001144769.2:c.14081A>G
  • NM_001723.5:c.*122471A>G
  • NM_015548.4:c.12569A>G
Protein change:
dbSNP: rs199628430
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_001144769.5:c.14081A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001144770.2:c.13667A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374722.1:c.20438A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374729.1:c.19478A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374730.1:c.13220A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374734.1:c.20465A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374736.1:c.20438A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001386100.1:c.13547A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_015548.5:c.12569A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_183380.4:c.13547A>G - missense variant - [Sequence Ontology: SO:0001583]


Hereditary sensory and autonomic neuropathy type 6
HSAN VI; Neuropathy, hereditary sensory and autonomic, type VI
MONDO: MONDO:0013839; MedGen: C3539003; Orphanet: 314381; OMIM: 614653

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV000745355Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus
criteria provided, single submitter

(ACGS Guidelines, 2013)
Uncertain significance
(May 2, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center - VKGL Data-share Consensus, SCV000745355.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 7, 2024